These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 38520822)
1. Microbial synthesis of health-promoting inositols. Yoshida KI; Bott M Curr Opin Biotechnol; 2024 Jun; 87():103114. PubMed ID: 38520822 [TBL] [Abstract][Full Text] [Related]
2. Physiological, Biochemical, and Structural Bioinformatic Analysis of the Multiple Inositol Dehydrogenases from Corynebacterium glutamicum. Ramp P; Pfleger C; Dittrich J; Mack C; Gohlke H; Bott M Microbiol Spectr; 2022 Oct; 10(5):e0195022. PubMed ID: 36094194 [TBL] [Abstract][Full Text] [Related]
3. Metabolic engineering of Corynebacterium glutamicum for production of scyllo-inositol, a drug candidate against Alzheimer's disease. Ramp P; Lehnert A; Matamouros S; Wirtz A; Baumgart M; Bott M Metab Eng; 2021 Sep; 67():173-185. PubMed ID: 34224896 [TBL] [Abstract][Full Text] [Related]
4. A bacterial cell factory converting glucose into scyllo-inositol, a therapeutic agent for Alzheimer's disease. Michon C; Kang CM; Karpenko S; Tanaka K; Ishikawa S; Yoshida KI Commun Biol; 2020 Mar; 3(1):93. PubMed ID: 32123276 [TBL] [Abstract][Full Text] [Related]
5. Alternative routes for production of the drug candidate d-chiro-inositol with Corynebacterium glutamicum using endogenous or promiscuous plant enzymes. Ramp P; Mack C; Wirtz A; Bott M Metab Eng; 2023 Jul; 78():1-10. PubMed ID: 37146873 [TBL] [Abstract][Full Text] [Related]
6. A cell factory of Bacillus subtilis engineered for the simple bioconversion of myo-inositol to scyllo-inositol, a potential therapeutic agent for Alzheimer's disease. Yamaoka M; Osawa S; Morinaga T; Takenaka S; Yoshida K Microb Cell Fact; 2011 Sep; 10():69. PubMed ID: 21896210 [TBL] [Abstract][Full Text] [Related]
7. Engineering Corynebacterium glutamicum for fast production of L-lysine and L-pipecolic acid. Pérez-García F; Peters-Wendisch P; Wendisch VF Appl Microbiol Biotechnol; 2016 Sep; 100(18):8075-90. PubMed ID: 27345060 [TBL] [Abstract][Full Text] [Related]
9. Current knowledge on isobutanol production with Escherichia coli, Bacillus subtilis and Corynebacterium glutamicum. Blombach B; Eikmanns BJ Bioeng Bugs; 2011; 2(6):346-50. PubMed ID: 22008938 [TBL] [Abstract][Full Text] [Related]
10. A new-generation of Bacillus subtilis cell factory for further elevated scyllo-inositol production. Tanaka K; Natsume A; Ishikawa S; Takenaka S; Yoshida KI Microb Cell Fact; 2017 Apr; 16(1):67. PubMed ID: 28431560 [TBL] [Abstract][Full Text] [Related]
11. Metabolic engineering Corynebacterium glutamicum for D-chiro-inositol production. Ji G; Jin X; Shi F World J Microbiol Biotechnol; 2024 Apr; 40(5):154. PubMed ID: 38568465 [TBL] [Abstract][Full Text] [Related]
12. Biosynthesis and production of quercitols and their application in the production of pharmaceuticals: current status and prospects. Itoh N Appl Microbiol Biotechnol; 2018 Jun; 102(11):4641-4651. PubMed ID: 29663050 [TBL] [Abstract][Full Text] [Related]
13. Enhancing fengycin production in the co-culture of Bacillus subtilis and Corynebacterium glutamicum by engineering proline transporter. Gao GR; Wei SY; Ding MZ; Hou ZJ; Wang DJ; Xu QM; Cheng JS; Yuan YJ Bioresour Technol; 2023 Sep; 383():129229. PubMed ID: 37244302 [TBL] [Abstract][Full Text] [Related]
14. Metabolic engineering of Corynebacterium glutamicum for enhanced production of 5-aminovaleric acid. Shin JH; Park SH; Oh YH; Choi JW; Lee MH; Cho JS; Jeong KJ; Joo JC; Yu J; Park SJ; Lee SY Microb Cell Fact; 2016 Oct; 15(1):174. PubMed ID: 27717386 [TBL] [Abstract][Full Text] [Related]
15. The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry). Thomas MP; Mills SJ; Potter BV Angew Chem Int Ed Engl; 2016 Jan; 55(5):1614-50. PubMed ID: 26694856 [TBL] [Abstract][Full Text] [Related]
16. Inositols: From Established Knowledge to Novel Approaches. Dinicola S; Unfer V; Facchinetti F; Soulage CO; Greene ND; Bizzarri M; Laganà AS; Chan SY; Bevilacqua A; Pkhaladze L; Benvenga S; Stringaro A; Barbaro D; Appetecchia M; Aragona C; Bezerra Espinola MS; Cantelmi T; Cavalli P; Chiu TT; Copp AJ; D'Anna R; Dewailly D; Di Lorenzo C; Diamanti-Kandarakis E; Hernández Marín I; Hod M; Kamenov Z; Kandaraki E; Monastra G; Montanino Oliva M; Nestler JE; Nordio M; Ozay AC; Papalou O; Porcaro G; Prapas N; Roseff S; Vazquez-Levin M; Vucenik I; Wdowiak A Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638926 [TBL] [Abstract][Full Text] [Related]
17. Bacillus subtilis IolQ (DegA) is a transcriptional repressor of iolX encoding NAD Kang DM; Michon C; Morinaga T; Tanaka K; Takenaka S; Ishikawa S; Yoshida KI BMC Microbiol; 2017 Jul; 17(1):154. PubMed ID: 28693424 [TBL] [Abstract][Full Text] [Related]
18. Metabolome analysis-based design and engineering of a metabolic pathway in Corynebacterium glutamicum to match rates of simultaneous utilization of D-glucose and L-arabinose. Kawaguchi H; Yoshihara K; Hara KY; Hasunuma T; Ogino C; Kondo A Microb Cell Fact; 2018 May; 17(1):76. PubMed ID: 29773073 [TBL] [Abstract][Full Text] [Related]
19. Engineering Corynebacterium glutamicum for the de novo biosynthesis of tailored poly-γ-glutamic acid. Xu G; Zha J; Cheng H; Ibrahim MHA; Yang F; Dalton H; Cao R; Zhu Y; Fang J; Chi K; Zheng P; Zhang X; Shi J; Xu Z; Gross RA; Koffas MAG Metab Eng; 2019 Dec; 56():39-49. PubMed ID: 31449877 [TBL] [Abstract][Full Text] [Related]
20. Differential substrate specificity of two inositol transporters of Bacillus subtilis. Morinaga T; Matsuse T; Ashida H; Yoshida K Biosci Biotechnol Biochem; 2010; 74(6):1312-4. PubMed ID: 20530884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]